FDA Finalizes Controversial Guidance on Livestock Antibiotic Use
The FDA issued final guidance advising drug companies to set duration limits for medically important antibiotics in livestock feed without legal obligation. Public health advocates criticize the guidance as insufficient to combat antibiotic resistance, which causes over 2.8 million infections and 35,000 deaths annually in the U.S.
The U.S. Food and Drug Administration published a final guidance document on February 17, 2026, advising drug companies to set "duration limits" for medically important antibiotics used in livestock feed, but without legally obligating them to do so. Public health advocates immediately criticized the move as a step backward in combating antibiotic resistance, which now causes over 2.8 million antibiotic-resistant infections and 35,000 deaths annually in the United States.
The guidance covers antibiotics deemed medically important because they are used in both animal agriculture and human medicine. When these drugs are administered for long periods to livestock, the risk of bacteria developing resistance increases. In announcing the guidance, the FDA stated it is "intended to mitigate development of antimicrobial resistance for these antimicrobial drugs." However, the agency did not include an upper time limit for all drugs, nor did it require companies to consider how duration limits might contribute to resistance that could harm humans.
The FDA's action comes just weeks after agency data revealed a 2024 spike in sales of medically important drugs for use in cattle, pigs, and poultry. It also follows years of effort by the FDA to push manufacturers to create duration limits for older drugs, though more than a quarter of those drugs still lack such limits. Under the new guidance, companies are asked to submit proposed duration limits—with both "typical" and "maximum" durations based on factors like disease risk and drug use—along with scientific justification for approval on drug labels within the next three years. None of these recommendations are legally binding.
The guidance was finalized after the agency received more than 4,500 comments on its 2023 draft proposal. According to the FDA, the vast majority of comments from advocates and individuals "requested that FDA limit all durations of use to no more than 21 days." Comments from industry associations, drug companies, and veterinary organizations raised concerns about timelines, clear labeling, and data transparency.
The new guidance follows a broader pattern of public health concern about antibiotic use in livestock. Earlier, more than 60 organizations filed a petition urging the FDA to withdraw approval for what they called the "unsafe" use of antibiotics for preventing disease in food-producing livestock. The groups noted that 34 million pounds of antibiotics are used in livestock feed and water to treat diagnosed diseases, contributing to the accumulation of bacteria resistant to antibiotics critical for human health.
Antibiotic resistance remains a significant public health threat. The majority of medically important antibiotics are used on animals, not on humans, and antibiotic use by concentrated animal-feeding operations is a leading factor in resistance development. The FDA has acknowledged that its regulation is insufficient to meaningfully prevent risks or reduce the volume of antibiotics sold to the animal agriculture industry.